These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1281216)

  • 41. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.
    Young AC; Zhang W; Sacchettini JC; Nathenson SG
    Cell; 1994 Jan; 76(1):39-50. PubMed ID: 7506996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
    Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
    J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An extensive region of an MHC class I alpha 2 domain loop influences interaction with the assembly complex.
    Yu YY; Turnquist HR; Myers NB; Balendiran GK; Hansen TH; Solheim JC
    J Immunol; 1999 Oct; 163(8):4427-33. PubMed ID: 10510384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides.
    Joyce S; Tabaczewski P; Angeletti RH; Nathenson SG; Stroynowski I
    J Exp Med; 1994 Feb; 179(2):579-88. PubMed ID: 8294869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.
    Ciatto C; Tissot AC; Tschopp M; Capitani G; Pecorari F; Plückthun A; Grütter MG
    J Mol Biol; 2001 Oct; 312(5):1059-71. PubMed ID: 11580250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
    Falk K; Rötzschke O; Stevanović S; Jung G; Rammensee HG
    Nature; 1991 May; 351(6324):290-6. PubMed ID: 1709722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peptide variants reveal how antibodies recognize major histocompatibility complex class I.
    Hogquist KA; Grandea AG; Bevan MJ
    Eur J Immunol; 1993 Nov; 23(11):3028-36. PubMed ID: 8223880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two alpha beta T cell receptors.
    Rognan D; Stryhn A; Fugger L; Lyngbaek S; Engberg J; Andersen PS; Buus S
    J Comput Aided Mol Des; 2000 Jan; 14(1):53-69. PubMed ID: 10702925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.
    Song ES; Linsk R; Olson CA; McMillan M; Goodenow RS
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1927-31. PubMed ID: 3258067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of a glycine in the alpha2 domain affects MHC peptide binding but not chaperone binding.
    Turnquist HR; Vargas SE; Solheim JC
    Biochem Biophys Res Commun; 2001 Dec; 289(4):825-31. PubMed ID: 11735120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular modeling of an antigenic complex between a viral peptide and a class I major histocompatibility glycoprotein.
    Rognan D; Reddehase MJ; Koszinowski UH; Folkers G
    Proteins; 1992 May; 13(1):70-85. PubMed ID: 1594579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation.
    Young AC; Nathenson SG; Sacchettini JC
    FASEB J; 1995 Jan; 9(1):26-36. PubMed ID: 7821756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.